Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 2 Trial of TD 6424 Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections
This study has been completed.
Study NCT00061633   Information provided by Theravance
First Received: May 30, 2003   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infections, Gram-Positive Bacterial
Abscess
Burns
Cellulitis
Ulcer
Wound Infections
Additional conditions recognized in this trial
Communicable Diseases
Gram-Positive Bacterial Infections
Infection
Wound Infection
More general conditions related to this trial
Bacterial Infections
Connective Tissue Diseases
Disorders of Environmental Origin
Inflammation
Pathologic Processes
Skin Diseases, Infectious
Suppuration
Wounds and Injuries
Interventions listed in this trial
TD-6424
Sponsors listed in this trial
Theravance


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services